Lammert Albers sits down with Proactive London's Andrew Scott soon after his appointment as IXICO PLC’s (LON:IXI) chief business officer.
With expertise of the Alzheimer's disease trials market he says he'll be responsible for executing the company's global business development strategy in both existing and new markets.